Global Passive Transdermal Drug Delivery Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

  • receipt Report ID : 81914
  • calendar_today Published On: Apr, 2021
  • file_copy Pages: 156
  • list Medical Devices
Buy @ $3500

The Passive Transdermal Drug Delivery market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Passive Transdermal Drug Delivery size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Passive Transdermal Drug Delivery market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation

Passive Transdermal Drug Delivery market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Microfluidics

Smart Pill Technology (SPT)

Market segment by Application can be divided into

Clinic

Hospital

Others

The key market players for global Passive Transdermal Drug Delivery market are listed below:

3M

Actavis, Inc.

Bayer AG

Boehringer Ingelheim GmbH

Corium International, Inc.

Echo Therapeutics, Inc.

GlaxoSmithKline plc

Johnson & Johnson (Janssen Pharmaceuticals Inc.)

Mylan N.V.

Novartis AG

Noven Pharmaceuticals, Inc.

Transdermal Corp.

Market segment by Region, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:

Chapter 1, to describe Passive Transdermal Drug Delivery product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Passive Transdermal Drug Delivery, with price, sales, revenue and global market share of Passive Transdermal Drug Delivery from 2019 to 2021.

Chapter 3, the Passive Transdermal Drug Delivery competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Passive Transdermal Drug Delivery breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.

Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Passive Transdermal Drug Delivery market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.

Chapter 12, 13 and 14, to describe Passive Transdermal Drug Delivery sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Passive Transdermal Drug Delivery Introduction

1.2 Market Analysis by Type

1.2.1 Overview: Global Passive Transdermal Drug Delivery Revenue by Type: 2019 Versus 2021 Versus 2026

1.2.2 Microfluidics

1.2.3 Smart Pill Technology (SPT)

1.3 Market Analysis by Application

1.3.1 Overview: Global Passive Transdermal Drug Delivery Revenue by Application: 2019 Versus 2021 Versus 2026

1.3.2 Clinic

1.3.3 Hospital

1.3.4 Others

1.4 Global Passive Transdermal Drug Delivery Market Size & Forecast

1.4.1 Global Passive Transdermal Drug Delivery Sales in Value (2016-2026))

1.4.2 Global Passive Transdermal Drug Delivery Sales in Volume (2016-2026)

1.4.3 Global Passive Transdermal Drug Delivery Price by Type (2016-2026) & (USD/Unit)

1.5 Global Passive Transdermal Drug Delivery Production Capacity Analysis

1.5.1 Global Passive Transdermal Drug Delivery Total Production Capacity (2016-2026)

1.5.2 Global Passive Transdermal Drug Delivery Production Capacity by Geographic Region

1.6 Market Drivers, Restraints and Trends

1.6.1 Passive Transdermal Drug Delivery Market Drivers

1.6.2 Passive Transdermal Drug Delivery Market Restraints

1.6.3 Passive Transdermal Drug Delivery Trends Analysis

2 Manufacturers Profiles

2.1 3M

2.1.1 3M Details

2.1.2 3M Major Business

2.1.3 3M Passive Transdermal Drug Delivery Product and Services

2.1.4 3M Passive Transdermal Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.2 Actavis, Inc.

2.2.1 Actavis, Inc. Details

2.2.2 Actavis, Inc. Major Business

2.2.3 Actavis, Inc. Passive Transdermal Drug Delivery Product and Services

2.2.4 Actavis, Inc. Passive Transdermal Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.3 Bayer AG

2.3.1 Bayer AG Details

2.3.2 Bayer AG Major Business

2.3.3 Bayer AG Passive Transdermal Drug Delivery Product and Services

2.3.4 Bayer AG Passive Transdermal Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.4 Boehringer Ingelheim GmbH

2.4.1 Boehringer Ingelheim GmbH Details

2.4.2 Boehringer Ingelheim GmbH Major Business

2.4.3 Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Product and Services

2.4.4 Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.5 Corium International, Inc.

2.5.1 Corium International, Inc. Details

2.5.2 Corium International, Inc. Major Business

2.5.3 Corium International, Inc. Passive Transdermal Drug Delivery Product and Services

2.5.4 Corium International, Inc. Passive Transdermal Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.6 Echo Therapeutics, Inc.

2.6.1 Echo Therapeutics, Inc. Details

2.6.2 Echo Therapeutics, Inc. Major Business

2.6.3 Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Product and Services

2.6.4 Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.7 GlaxoSmithKline plc

2.7.1 GlaxoSmithKline plc Details

2.7.2 GlaxoSmithKline plc Major Business

2.7.3 GlaxoSmithKline plc Passive Transdermal Drug Delivery Product and Services

2.7.4 GlaxoSmithKline plc Passive Transdermal Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.8 Johnson & Johnson (Janssen Pharmaceuticals Inc.)

2.8.1 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Details

2.8.2 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Major Business

2.8.3 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Product and Services

2.8.4 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.9 Mylan N.V.

2.9.1 Mylan N.V. Details

2.9.2 Mylan N.V. Major Business

2.9.3 Mylan N.V. Passive Transdermal Drug Delivery Product and Services

2.9.4 Mylan N.V. Passive Transdermal Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.10 Novartis AG

2.10.1 Novartis AG Details

2.10.2 Novartis AG Major Business

2.10.3 Novartis AG Passive Transdermal Drug Delivery Product and Services

2.10.4 Novartis AG Passive Transdermal Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.11 Noven Pharmaceuticals, Inc.

2.11.1 Noven Pharmaceuticals, Inc. Details

2.11.2 Noven Pharmaceuticals, Inc. Major Business

2.11.3 Noven Pharmaceuticals, Inc. Passive Transdermal Drug Delivery Product and Services

2.11.4 Noven Pharmaceuticals, Inc. Passive Transdermal Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.12 Transdermal Corp.

2.12.1 Transdermal Corp. Details

2.12.2 Transdermal Corp. Major Business

2.12.3 Transdermal Corp. Passive Transdermal Drug Delivery Product and Services

2.12.4 Transdermal Corp. Passive Transdermal Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

3 Passive Transdermal Drug Delivery Sales by Manufacturer

3.1 Global Passive Transdermal Drug Delivery Sales in Volume by Manufacturer (2019-2021e)

3.2 Global Passive Transdermal Drug Delivery Revenue by Manufacturer (2019-2021e)

3.3 Key Manufacturer Market Position in Passive Transdermal Drug Delivery

3.4 Market Concentration Rate

3.4.1 Top 3 Passive Transdermal Drug Delivery Manufacturer Market Share

3.4.2 Top 6 Passive Transdermal Drug Delivery Manufacturer Market Share

3.5 Global Passive Transdermal Drug Delivery Production Capacity by Company

3.6 Manufacturer by Geography: Head Office and Passive Transdermal Drug Delivery Production Site

3.7 New Entrant and Capacity Expansion Plans

3.8 Mergers & Acquisitions

4 Market Analysis by Region

4.1 Global Passive Transdermal Drug Delivery Market Size by Region

4.1.1 Global Passive Transdermal Drug Delivery Sales in Volume by Region (2016-2026)

4.1.2 Global Passive Transdermal Drug Delivery Revenue by Region (2016-2026)

4.2 North America Passive Transdermal Drug Delivery Revenue (2016-2026)

4.3 Europe Passive Transdermal Drug Delivery Revenue (2016-2026)

4.4 Asia-Pacific Passive Transdermal Drug Delivery Revenue (2016-2026)

4.5 South America Passive Transdermal Drug Delivery Revenue (2016-2026)

4.6 Middle East and Africa Passive Transdermal Drug Delivery Revenue (2016-2026)

5 Market Segment by Type

5.1 Global Passive Transdermal Drug Delivery Sales in Volume by Type (2016-2026)

5.2 Global Passive Transdermal Drug Delivery Revenue by Type (2016-2026)

5.3 Global Passive Transdermal Drug Delivery Price by Type (2016-2026)

6 Market Segment by Application

6.1 Global Passive Transdermal Drug Delivery Sales in Volume by Application (2016-2026)

6.2 Global Passive Transdermal Drug Delivery Revenue by Application (2016-2026)

6.3 Global Passive Transdermal Drug Delivery Price by Application (2016-2026)

7 North America by Country, by Type, and by Application

7.1 North America Passive Transdermal Drug Delivery Sales by Type (2016-2026)

7.2 North America Passive Transdermal Drug Delivery Sales by Application (2016-2026)

7.3 North America Passive Transdermal Drug Delivery Market Size by Country

7.3.1 North America Passive Transdermal Drug Delivery Sales in Volume by Country (2016-2026)

7.3.2 North America Passive Transdermal Drug Delivery Revenue by Country (2016-2026)

7.3.3 United States Market Size and Forecast (2016-2026)

7.3.4 Canada Market Size and Forecast (2016-2026)

7.3.5 Mexico Market Size and Forecast (2016-2026)

8 Europe by Country, by Type, and by Application

8.1 Europe Passive Transdermal Drug Delivery Sales by Type (2016-2026)

8.2 Europe Passive Transdermal Drug Delivery Sales by Application (2016-2026)

8.3 Europe Passive Transdermal Drug Delivery Market Size by Country

8.3.1 Europe Passive Transdermal Drug Delivery Sales in Volume by Country (2016-2026)

8.3.2 Europe Passive Transdermal Drug Delivery Revenue by Country (2016-2026)

8.3.3 Germany Market Size and Forecast (2016-2026)

8.3.4 France Market Size and Forecast (2016-2026)

8.3.5 United Kingdom Market Size and Forecast (2016-2026)

8.3.6 Russia Market Size and Forecast (2016-2026)

8.3.7 Italy Market Size and Forecast (2016-2026)

9 Asia-Pacific by Country, by Type, and by Application

9.1 Asia-Pacific Passive Transdermal Drug Delivery Sales by Type (2016-2026)

9.2 Asia-Pacific Passive Transdermal Drug Delivery Sales by Application (2016-2026)

9.3 Asia-Pacific Passive Transdermal Drug Delivery Market Size by Region

9.3.1 Asia-Pacific Passive Transdermal Drug Delivery Sales in Volume by Region (2016-2026)

9.3.2 Asia-Pacific Passive Transdermal Drug Delivery Revenue by Region (2016-2026)

9.3.3 China Market Size and Forecast (2016-2026)

9.3.4 Japan Market Size and Forecast (2016-2026)

9.3.5 Korea Market Size and Forecast (2016-2026)

9.3.6 India Market Size and Forecast (2016-2026)

9.3.7 Southeast Asia Market Size and Forecast (2016-2026)

9.3.8 Australia Market Size and Forecast (2016-2026)

10 South America by Country, by Type, and by Application

10.1 South America Passive Transdermal Drug Delivery Sales by Type (2016-2026)

10.2 South America Passive Transdermal Drug Delivery Sales by Application (2016-2026)

10.3 South America Passive Transdermal Drug Delivery Market Size by Country

10.3.1 South America Passive Transdermal Drug Delivery Sales in Volume by Country (2016-2026)

10.3.2 South America Passive Transdermal Drug Delivery Revenue by Country (2016-2026)

10.3.3 Brazil Market Size and Forecast (2016-2026)

10.3.4 Argentina Market Size and Forecast (2016-2026)

11 Middle East & Africa by Country, by Type, and by Application

11.1 Middle East & Africa Passive Transdermal Drug Delivery Sales by Type (2016-2026)

11.2 Middle East & Africa Passive Transdermal Drug Delivery Sales by Application (2016-2026)

11.3 Middle East & Africa Passive Transdermal Drug Delivery Market Size by Country

11.3.1 Middle East & Africa Passive Transdermal Drug Delivery Sales in Volume by Country (2016-2026)

11.3.2 Middle East & Africa Passive Transdermal Drug Delivery Revenue by Country (2016-2026)

11.3.3 Turkey Market Size and Forecast (2016-2026)

11.3.4 Egypt Market Size and Forecast (2016-2026)

11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)

11.3.6 South Africa Market Size and Forecast (2016-2026)

12 Sales Channel, Distributors, Traders and Dealers

12.1 Sales Channel

12.1.1 Direct Marketing

12.1.2 Indirect Marketing

12.2 Passive Transdermal Drug Delivery Typical Distributors

12.3 Passive Transdermal Drug Delivery Typical Customers

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Research Process and Data Source

14.3 Disclaimer

List of Tables

Table 1. Global Passive Transdermal Drug Delivery Revenue by Type, (USD Million), 2021-2026

Table 2. Global Passive Transdermal Drug Delivery Revenue by Application, (USD Million), 2021-2026

Table 3. 3M Basic Information, Manufacturing Base and Competitors

Table 4. 3M Major Business

Table 5. 3M Passive Transdermal Drug Delivery Product and Services

Table 6. 3M Passive Transdermal Drug Delivery Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 7. Actavis, Inc. Basic Information, Manufacturing Base and Competitors

Table 8. Actavis, Inc. Major Business

Table 9. Actavis, Inc. Passive Transdermal Drug Delivery Product and Services

Table 10. Actavis, Inc. Passive Transdermal Drug Delivery Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 11. Bayer AG Basic Information, Manufacturing Base and Competitors

Table 12. Bayer AG Major Business

Table 13. Bayer AG Passive Transdermal Drug Delivery Product and Services

Table 14. Bayer AG Passive Transdermal Drug Delivery Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 15. Boehringer Ingelheim GmbH Basic Information, Manufacturing Base and Competitors

Table 16. Boehringer Ingelheim GmbH Major Business

Table 17. Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Product and Services

Table 18. Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 19. Corium International, Inc. Basic Information, Manufacturing Base and Competitors

Table 20. Corium International, Inc. Major Business

Table 21. Corium International, Inc. Passive Transdermal Drug Delivery Product and Services

Table 22. Corium International, Inc. Passive Transdermal Drug Delivery Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 23. Echo Therapeutics, Inc. Basic Information, Manufacturing Base and Competitors

Table 24. Echo Therapeutics, Inc. Major Business

Table 25. Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Product and Services

Table 26. Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 27. GlaxoSmithKline plc Basic Information, Manufacturing Base and Competitors

Table 28. GlaxoSmithKline plc Major Business

Table 29. GlaxoSmithKline plc Passive Transdermal Drug Delivery Product and Services

Table 30. GlaxoSmithKline plc Passive Transdermal Drug Delivery Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 31. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Basic Information, Manufacturing Base and Competitors

Table 32. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Major Business

Table 33. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Product and Services

Table 34. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 35. Mylan N.V. Basic Information, Manufacturing Base and Competitors

Table 36. Mylan N.V. Major Business

Table 37. Mylan N.V. Passive Transdermal Drug Delivery Product and Services

Table 38. Mylan N.V. Passive Transdermal Drug Delivery Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 39. Novartis AG Basic Information, Manufacturing Base and Competitors

Table 40. Novartis AG Major Business

Table 41. Novartis AG Passive Transdermal Drug Delivery Product and Services

Table 42. Novartis AG Passive Transdermal Drug Delivery Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 43. Noven Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors

Table 44. Noven Pharmaceuticals, Inc. Major Business

Table 45. Noven Pharmaceuticals, Inc. Passive Transdermal Drug Delivery Product and Services

Table 46. Noven Pharmaceuticals, Inc. Passive Transdermal Drug Delivery Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 47. Transdermal Corp. Basic Information, Manufacturing Base and Competitors

Table 48. Transdermal Corp. Major Business

Table 49. Transdermal Corp. Passive Transdermal Drug Delivery Product and Services

Table 50. Transdermal Corp. Passive Transdermal Drug Delivery Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 51. Global Passive Transdermal Drug Delivery Sales by Manufacturer (2019-2021e) & (K Units)

Table 52. Global Passive Transdermal Drug Delivery Revenue by Manufacturer (2019-2021e) & (USD Million)

Table 53. Market Position of Manufacturers in Passive Transdermal Drug Delivery, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020

Table 54. Global Passive Transdermal Drug Delivery Production Capacity by Company, (K Units): 2020 VS 2021

Table 55. Head Office and Passive Transdermal Drug Delivery Production Site of Key Manufacturer

Table 56. Passive Transdermal Drug Delivery New Entrant and Capacity Expansion Plans

Table 57. Passive Transdermal Drug Delivery Mergers & Acquisitions in the Past Five Years

Table 58. Global Passive Transdermal Drug Delivery Sales by Region (2016-2021e) & (K Units)

Table 59. Global Passive Transdermal Drug Delivery Sales by Region (2021-2026) & (K Units)

Table 60. Global Passive Transdermal Drug Delivery Revenue by Region (2016-2021e) & (USD Million)

Table 61. Global Passive Transdermal Drug Delivery Revenue by Region (2021-2026) & (USD Million)

Table 62. Global Passive Transdermal Drug Delivery Sales by Type (2016-2021e) & (K Units)

Table 63. Global Passive Transdermal Drug Delivery Sales by Type (2021-2026) & (K Units)

Table 64. Global Passive Transdermal Drug Delivery Revenue by Type (2016-2021e) & (USD Million)

Table 65. Global Passive Transdermal Drug Delivery Revenue by Type (2021-2026) & (USD Million)

Table 66. Global Passive Transdermal Drug Delivery Price by Type (2016-2021e) & (USD/Unit)

Table 67. Global Passive Transdermal Drug Delivery Price by Type (2021-2026) & (USD/Unit)

Table 68. Global Passive Transdermal Drug Delivery Sales by Application (2016-2021e) & (K Units)

Table 69. Global Passive Transdermal Drug Delivery Sales by Application (2021-2026) & (K Units)

Table 70. Global Passive Transdermal Drug Delivery Revenue by Application (2016-2021e) & (USD Million)

Table 71. Global Passive Transdermal Drug Delivery Revenue by Application (2021-2026) & (USD Million)

Table 72. Global Passive Transdermal Drug Delivery Price by Application (2016-2021e) & (USD/Unit)

Table 73. Global Passive Transdermal Drug Delivery Price by Application (2021-2026) & (USD/Unit)

Table 74. North America Passive Transdermal Drug Delivery Sales by Country (2016-2021e) & (K Units)

Table 75. North America Passive Transdermal Drug Delivery Sales by Country (2021-2026) & (K Units)

Table 76. North America Passive Transdermal Drug Delivery Revenue by Country (2016-2021e) & (USD Million)

Table 77. North America Passive Transdermal Drug Delivery Revenue by Country (2021-2026) & (USD Million)

Table 78. North America Passive Transdermal Drug Delivery Sales by Type (2016-2021e) & (K Units)

Table 79. North America Passive Transdermal Drug Delivery Sales by Type (2021-2026) & (K Units)

Table 80. North America Passive Transdermal Drug Delivery Sales by Application (2016-2021e) & (K Units)

Table 81. North America Passive Transdermal Drug Delivery Sales by Application (2021-2026) & (K Units)

Table 82. Europe Passive Transdermal Drug Delivery Sales by Country (2016-2021e) & (K Units)

Table 83. Europe Passive Transdermal Drug Delivery Sales by Country (2021-2026) & (K Units)

Table 84. Europe Passive Transdermal Drug Delivery Revenue by Country (2016-2021e) & (USD Million)

Table 85. Europe Passive Transdermal Drug Delivery Revenue by Country (2021-2026) & (USD Million)

Table 86. Europe Passive Transdermal Drug Delivery Sales by Type (2016-2021e) & (K Units)

Table 87. Europe Passive Transdermal Drug Delivery Sales by Type (2021-2026) & (K Units)

Table 88. Europe Passive Transdermal Drug Delivery Sales by Application (2016-2021e) & (K Units)

Table 89. Europe Passive Transdermal Drug Delivery Sales by Application (2021-2026) & (K Units)

Table 90. Asia-Pacific Passive Transdermal Drug Delivery Sales by Region (2016-2021e) & (K Units)

Table 91. Asia-Pacific Passive Transdermal Drug Delivery Sales by Region (2021-2026) & (K Units)

Table 92. Asia-Pacific Passive Transdermal Drug Delivery Revenue by Region (2016-2021e) & (USD Million)

Table 93. Asia-Pacific Passive Transdermal Drug Delivery Revenue by Region (2021-2026) & (USD Million)

Table 94. Asia-Pacific Passive Transdermal Drug Delivery Sales by Type (2016-2021e) & (K Units)

Table 95. Asia-Pacific Passive Transdermal Drug Delivery Sales by Type (2021-2026) & (K Units)

Table 96. Asia-Pacific Passive Transdermal Drug Delivery Sales by Application (2016-2021e) & (K Units)

Table 97. Asia-Pacific Passive Transdermal Drug Delivery Sales by Application (2021-2026) & (K Units)

Table 98. South America Passive Transdermal Drug Delivery Sales by Country (2016-2021e) & (K Units)

Table 99. South America Passive Transdermal Drug Delivery Sales by Country (2021-2026) & (K Units)

Table 100. South America Passive Transdermal Drug Delivery Revenue by Country (2016-2021e) & (USD Million)

Table 101. South America Passive Transdermal Drug Delivery Revenue by Country (2021-2026) & (USD Million)

Table 102. South America Passive Transdermal Drug Delivery Sales by Type (2016-2021e) & (K Units)

Table 103. South America Passive Transdermal Drug Delivery Sales by Type (2021-2026) & (K Units)

Table 104. South America Passive Transdermal Drug Delivery Sales by Application (2016-2021e) & (K Units)

Table 105. South America Passive Transdermal Drug Delivery Sales by Application (2021-2026) & (K Units)

Table 106. Middle East & Africa Passive Transdermal Drug Delivery Sales by Country (2016-2021e) & (K Units)

Table 107. Middle East & Africa Passive Transdermal Drug Delivery Sales by Country (2021-2026) & (K Units)

Table 108. Middle East & Africa Passive Transdermal Drug Delivery Revenue by Country (2016-2021e) & (USD Million)

Table 109. Middle East & Africa Passive Transdermal Drug Delivery Revenue by Country (2021-2026) & (USD Million)

Table 110. Middle East & Africa Passive Transdermal Drug Delivery Sales by Type (2016-2021e) & (K Units)

Table 111. Middle East & Africa Passive Transdermal Drug Delivery Sales by Type (2021-2026) & (K Units)

Table 112. Middle East & Africa Passive Transdermal Drug Delivery Sales by Application (2016-2021e) & (K Units)

Table 113. Middle East & Africa Passive Transdermal Drug Delivery Sales by Application (2021-2026) & (K Units)

Table 114. Direct Channel Pros & Cons

Table 115. Indirect Channel Pros & Cons

Table 116. Passive Transdermal Drug Delivery Typical Distributors

Table 117. Passive Transdermal Drug Delivery Typical Customers

List of Figures

Figure 1. Passive Transdermal Drug Delivery Picture

Figure 2. Global Passive Transdermal Drug Delivery Sales Market Share by Type in 2020

Figure 3. Microfluidics

Figure 4. Smart Pill Technology (SPT)

Figure 5. Global Passive Transdermal Drug Delivery Sales Market Share by Application in 2020

Figure 6. Clinic

Figure 7. Hospital

Figure 8. Others

Figure 9. Global Passive Transdermal Drug Delivery Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026

Figure 10. Global Passive Transdermal Drug Delivery Market Size and Forecast (2016-2026) & (USD Million)

Figure 11. Global Passive Transdermal Drug Delivery Sales (2016-2026) & (K Units)

Figure 12. Global Passive Transdermal Drug Delivery Price by Type (2016-2026) & (USD/Unit)

Figure 13. Global Passive Transdermal Drug Delivery Production Capacity (2016-2026) & (K Units)

Figure 14. Global Passive Transdermal Drug Delivery Production Capacity by Geographic Region: 2020 VS 2021

Figure 15. Passive Transdermal Drug Delivery Market Drivers

Figure 16. Passive Transdermal Drug Delivery Market Restraints

Figure 17. Passive Transdermal Drug Delivery Market Trends

Figure 18. Global Passive Transdermal Drug Delivery Sales Market Share by Manufacturer in 2020

Figure 19. Global Passive Transdermal Drug Delivery Revenue Market Share by Manufacturer in 2020

Figure 20. Passive Transdermal Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 21. Top 3 Passive Transdermal Drug Delivery Manufacturer (Revenue) Market Share in 2020

Figure 22. Top 6 Passive Transdermal Drug Delivery Manufacturer (Revenue) Market Share in 2020

Figure 23. Global Passive Transdermal Drug Delivery Sales Market Share by Region (2016-2026)

Figure 24. Global Passive Transdermal Drug Delivery Revenue Market Share by Region (2016-2026)

Figure 25. North America Passive Transdermal Drug Delivery Revenue (2016-2026) & (USD Million)

Figure 26. Europe Passive Transdermal Drug Delivery Revenue (2016-2026) & (USD Million)

Figure 27. Asia-Pacific Passive Transdermal Drug Delivery Revenue (2016-2026) & (USD Million)

Figure 28. South America Passive Transdermal Drug Delivery Revenue (2016-2026) & (USD Million)

Figure 29. Middle East & Africa Passive Transdermal Drug Delivery Revenue (2016-2026) & (USD Million)

Figure 30. Global Passive Transdermal Drug Delivery Sales Market Share by Type (2016-2026)

Figure 31. Global Passive Transdermal Drug Delivery Revenue Market Share by Type (2016-2026)

Figure 32. Global Passive Transdermal Drug Delivery Price by Type (2016-2026) & (USD/Unit)

Figure 33. Global Passive Transdermal Drug Delivery Sales Market Share by Application (2016-2026)

Figure 34. Global Passive Transdermal Drug Delivery Revenue Market Share by Application (2016-2026)

Figure 35. Global Passive Transdermal Drug Delivery Price by Application (2016-2026) & (USD/Unit)

Figure 36. North America Passive Transdermal Drug Delivery Sales Market Share by Type (2016-2026)

Figure 37. North America Passive Transdermal Drug Delivery Sales Market Share by Application (2016-2026)

Figure 38. North America Passive Transdermal Drug Delivery Sales Market Share by Country (2016-2026)

Figure 39. North America Passive Transdermal Drug Delivery Revenue Market Share by Country (2016-2026)

Figure 40. United States Passive Transdermal Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 41. Canada Passive Transdermal Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 42. Mexico Passive Transdermal Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 43. Europe Passive Transdermal Drug Delivery Sales Market Share by Type (2016-2026)

Figure 44. Europe Passive Transdermal Drug Delivery Sales Market Share by Application (2016-2026)

Figure 45. Europe Passive Transdermal Drug Delivery Sales Market Share by Country (2016-2026)

Figure 46. Europe Passive Transdermal Drug Delivery Revenue Market Share by Country (2016-2026)

Figure 47. Germany Passive Transdermal Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 48. France Passive Transdermal Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 49. United Kingdom Passive Transdermal Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 50. Russia Passive Transdermal Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 51. Italy Passive Transdermal Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 52. Asia-Pacific Passive Transdermal Drug Delivery Sales Market Share by Region (2016-2026)

Figure 53. Asia-Pacific Passive Transdermal Drug Delivery Sales Market Share by Application (2016-2026)

Figure 54. Asia-Pacific Passive Transdermal Drug Delivery Sales Market Share by Region (2016-2026)

Figure 55. Asia-Pacific Passive Transdermal Drug Delivery Revenue Market Share by Region (2016-2026)

Figure 56. China Passive Transdermal Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 57. Japan Passive Transdermal Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. Korea Passive Transdermal Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 59. India Passive Transdermal Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 60. Southeast Asia Passive Transdermal Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 61. Australia Passive Transdermal Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 62. South America Passive Transdermal Drug Delivery Sales Market Share by Type (2016-2026)

Figure 63. South America Passive Transdermal Drug Delivery Sales Market Share by Application (2016-2026)

Figure 64. South America Passive Transdermal Drug Delivery Sales Market Share by Country (2016-2026)

Figure 65. South America Passive Transdermal Drug Delivery Revenue Market Share by Country (2016-2026)

Figure 66. Brazil Passive Transdermal Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 67. Argentina Passive Transdermal Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 68. Middle East & Africa Passive Transdermal Drug Delivery Sales Market Share by Type (2016-2026)

Figure 69. Middle East & Africa Passive Transdermal Drug Delivery Sales Market Share by Application (2016-2026)

Figure 70. Middle East & Africa Passive Transdermal Drug Delivery Sales Market Share by Country (2016-2026)

Figure 71. Middle East & Africa Passive Transdermal Drug Delivery Revenue Market Share by Country (2016-2026)

Figure 72. Turkey Passive Transdermal Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 73. Egypt Passive Transdermal Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 74. Saudi Arabia Passive Transdermal Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 75. South Africa Passive Transdermal Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 76. Sales Channel: Direct Channel vs Indirect Channel

Figure 77. Methodology

Figure 78. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

+1

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketquest.biz